Insulin Therapy in Type 2 Diabetes Mellitus: the Need for Early Initiation and Opportunity to Choose
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 3, Issue 67
Abstract
Achieving target values of glycemic profile — the main objective of therapy for type 2 diabetes mellitus (DM2). Early administration of insulin enables not only to lower glycemic parameters quickly and effectively and to compensate carbohydrate metabolism, but also to reduce the risk of cardiovascular complications. Early and reasonable administration of insulin, timely titration of its dose — determinants of achieving target blood glucose levels in patients with DM2, and provide numerous opportunities to achieve the main goals of DM treatment — maintenance of long-term metabolic control and prevention or delay of vascular complications.
Authors and Affiliations
I. Yu. Golovach, O. V. Diachоk
Keywords
Related Articles
- EP ID EP222614
- DOI -
- Views 44
- Downloads 0
Carbohydrate Metabolism in Young Women with Primary Obesity
We have studied the carbohydrate metabolism in 241 young women — 16–45 years (mean age — 28.5 ± 7.0 years) with primary obesity (body mass index 26 to 62 kg/m2). It was found that 64 % of women with primary obesity had...
McCune-Albright-Braytsev syndrome: literature review and clinical case
The paper presents the results of literature review on McCune-Albright-Braytsev syndrome and describes the clinical case of this syndrome. McCune-Albright-Braytsev syndrome is a genetically determined disease, usually ch...
Some aspects concerning abdominal obesity diagnosis in city population of Ukraine
Background. Optimized preventive approaches concerning the development of comorbidity in the patients with overweight of various degree is a topical issue of medical science. Efficiency of such approaches depends on a wh...
Focal Pathology of the Thyroid Gland, Modern Echodiagnostics
The article deals with focal lesions in the thyroid gland. Sonographic characteristics of nodular goiter, adenomas, cysts, malignant tumors is presented.
Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2
The article deals with one of the most urgent and important socio-economic problems of clinical endocrinology — diabetes mellitus (DM). With the progression of DM, it is harder to control the disease; in this regard, ins...